In the Directors' report,"the future rate of growth is dependent to a large degree"..on the "Key Opinion Leaders".There needs to be a transformation in medical establishment's approach to asthma management:a shift in their thinking.The outsourcing of medical treatment runs into major headwinds:the pharmaceutical industry and the allopathic tendency to focus on alleviating symptoms rather than promoting self-management devices.KSX recognizes that they are at the mercy of these opinion leaders. As a long-term holder,I have envisaged that the hospital system will be stressed by the rising lung-related illnesses and that Government will promote such outsourcing.
Cheers to all holders
KSX Price at posting:
1.3¢ Sentiment: Hold Disclosure: Held